Loading the list…

LB Pharmaceuticals Inc (LBRX)

Nasdaq · LBRX

connecting

$43.01+1.30%

Closing prices for 13 November 2026

Loading chart

Company valuation

The series is stated in the current share scale after splits; dividends are not included in the price

Loading the list…

Nasdaq · LBRX

connecting

$43.01+1.30%

Closing prices for 13 November 2026

Loading chart

The series is stated in the current share scale after splits; dividends are not included in the price

Volatility 90d

61.20%

Place in range

80.01%

Current ratio

15.1

Net income, last year

−$86M

Earnings per share

$22.81

Based on the last 12 months of reports, through 30 June 2026

The sector median covers every company in the sector on the US market, loss-making ones included.

How to read the figures

Market capitalisation is the value of all of a company's shares at the current price: the price of one share times the number of shares.
P/B (price / book) is market capitalisation divided by shareholders' equity: below one means the market values the company under its accounting assets net of debt.
ROE (return on equity) is net income over 12 months divided by shareholders' equity: how much profit the company earns on each unit of its owners' capital.
ROA (return on assets) is net income divided by total assets: how efficiently the company uses what it owns.
The current ratio is current assets divided by short-term liabilities: whether the company has enough cash and inventory to pay its nearest debts.